VC firm
Delos Capital
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- George Town, Cayman Islands
- Founded
- 2014
- Assets under management
- $482MForm ADV private fund GAV, as of 2026-03-27Source (opens in a new tab)
- Latest fund size
- $300MSEC amount sold, as of 2022-01-27Source (opens in a new tab)
- Funds
- 5
- Legal name
- Delos Capital Management, LP
Claim, correct or request removal
Record updated 30 September 2026
About
We empower life sciences leaders to turn bold ideas into medical breakthroughs.
Investment approach
- Thesis
- Our rigorous investment process combines a deep understanding of biology, unmet needs in medicine, and building high-performing companies to bring medical breakthroughs to patients.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Tim led the firm’s investments in and serves on the boards of Curatia Medical, Eccogene, LipoSeuticals, ReNiva, STRM.Bio, and Zenas.
- Investing status notes
- Investing in impactful solutions poised to make a difference for patients.
Funds
- Delos Capital Fund III, LP
- $300MVintage 2022, Main fund, SEC amount sold
- Delos Capital Fund, LP
- $130MVintage 2014, SEC amount sold
- DELOS CAPITAL FUND II, L.P.
- Main fund
- DELOS CAPITAL FUND, L.P.
- Main fund
- DELOS CAPITAL FUND III, LP
- Main fund
SEC registration
- Registered adviser
- DELOS CAPITAL ADVISORS LLC
- CRD number
- 335144 (opens in a new tab)
- SEC file number
- 802-132415
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $482Mas of 2026-03-27
- Private funds reported
- 3
- Principal office
- GEORGE TOWN, Cayman Islands
Locations
- Office
- Cambridge, MA
- Office
- Hong Kong
Loading relationship preview